A no serum EGF 100 ng/ml BoiRNA: 0 GL2 • SC4MOLSIRNA~~~ ~§0 2 4 ~E0 2 Tim9 wi1lt EGF 100 ng/ml, hrs D 2500 C•«u•lm"b 0. 75 mifkg l l ~ ~ ~ 2000 'E E 1500 l 0 > a 1000 E i= c ~ ~ 1.:lli}Efj 1.:wnpYr; .:hlil; l :pT1~4821.hlt1.:hlnpERK ~ 1 • • 1 • 1 I ~ I 1 ~Ill D ays °5 ~0 5 0. 5 0.5 * 0 5 * SJE no serum ertotinib EGF 100 nglml fo>_>_o o o oIIRNA~ 12 hrs ~~ }, o ~ .,f g pT308·AKT pS473·AK T pS6K pS6 1.5 pY1173·EGFR pT202lY204-ER K1/2 1.5 1.:llil· 1: 1. 5 i .., ~ ~ n II} '11aiRNA: 1.5 OGU m , nI 1 • 1 0•5 * 0 .5 0.5 0 ~ • ~.0 00-511~22.5 <.>~~~ 1 * 0.5 ·:~·r~ "' 0 0 0.5 1 1.5 2 2.5 0 0.5 1 1.5 2 2.5 ErloUnlb. ~tM ::~pT20v:204-ERK 10 * 5 0 0 2 4 ahCont rol EGFR En>B21 pT1221 /1222 '-;;-:--'";"":"""':':""-:;":;----;"7'"""""':;-;-~~-'";:-;-~:-:;--;:-:-;:-:-~ AKT P70S6K pT389 P70S6K 56 ERK pT202lY204 ERK a ·tubulln • SC4MOL 10 0.5 